Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1.


Journal

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology
ISSN: 1557-1904
Titre abrégé: J Neuroimmune Pharmacol
Pays: United States
ID NLM: 101256586

Informations de publication

Date de publication:
03 2019
Historique:
received: 17 04 2018
accepted: 26 06 2018
pubmed: 12 7 2018
medline: 15 9 2020
entrez: 12 7 2018
Statut: ppublish

Résumé

HIV-1 persists in cellular reservoirs that cannot be eliminated by antiretroviral therapy (ART). The major reservoir in infected individuals on effective ART is composed of resting memory CD4+ T cells that harbor proviral cDNA, and undergo a state of latency in which viral gene expression is minimal to absent. The CD4+ T cell reservoir has been extensively characterized. However, other HIV-1-permissive cells may contribute to HIV-1 persistence. Lentiviruses have a long recognized association with macrophages. However, the role, if any, played by macrophages in HIV-1 persistence is not well understood. Macrophages are resistant to cell death upon HIV-1 infection, and can survive for long periods of time, making them ideal host cells in which the virus might persist. Studying macrophages is challenging, as these cells reside in nearly all tissues. Moreover, detecting viral DNA or RNA in macrophages does not necessarily indicate that these cells will produce replication-competent viral particles. Currently, the gold standard assay to detect cellular reservoirs is the ex vivo quantitative viral outgrowth assay (QVOA), which requires a patient blood draw. However, macrophages reside deep within tissues that are inaccessible in living subjects, such as the central nervous system (CNS). Therefore, tools other than QVOA must be developed to identify cellular reservoirs that reside in the tissues. In this review, we will focus on the main aspects involved in HIV-1 persistence, including the molecular mechanisms of viral evasion, the main cell types responsible for harboring persistent HIV-1 and the tissue compartments that are likely to be reservoirs for HIV-1.

Identifiants

pubmed: 29995208
doi: 10.1007/s11481-018-9795-4
pii: 10.1007/s11481-018-9795-4
pmc: PMC6927576
mid: NIHMS1019470
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-43

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI096109
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH093306
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI073961
Pays : United States
Organisme : NIMH NIH HHS
ID : P01 MH100942
Pays : United States

Références

J Neuroinflammation. 2016 Oct 14;13(1):272
pubmed: 27737697
J Biol Chem. 2015 Dec 11;290(50):30078-86
pubmed: 26483545
PLoS One. 2015 Jun 19;10(6):e0129425
pubmed: 26090662
J Biol Chem. 2005 Apr 1;280(13):12840-8
pubmed: 15653685
J Neuroinflammation. 2011 Oct 25;8:145
pubmed: 22027397
AIDS Patient Care STDS. 2014 Sep;28(9):462-74
pubmed: 25045996
Cell Host Microbe. 2014 Dec 10;16(6):711-21
pubmed: 25467409
N Engl J Med. 2009 Feb 12;360(7):692-8
pubmed: 19213682
MBio. 2017 Aug 15;8(4):
pubmed: 28811349
J Acquir Immune Defic Syndr. 1993 Jul;6(7):772-7
pubmed: 8099611
Cell. 1990 Apr 20;61(2):213-22
pubmed: 2331748
PLoS Pathog. 2007 Sep 7;3(9):1281-90
pubmed: 17907802
J Neurovirol. 2003 Apr;9(2):222-7
pubmed: 12707852
Science. 1983 May 20;220(4599):868-71
pubmed: 6189183
Prog Brain Res. 1983;59:233-5
pubmed: 6320268
J Exp Med. 2017 Apr 3;214(4):959-972
pubmed: 28341641
J Virol. 2009 Apr;83(7):3258-67
pubmed: 19153236
Infect Immun. 1983 Aug;41(2):837-40
pubmed: 6307885
J Neurovirol. 2001 Dec;7(6):528-41
pubmed: 11704885
Infect Drug Resist. 2017 Oct 16;10:343-352
pubmed: 29081666
Immunity. 2014 Sep 18;41(3):493-502
pubmed: 25238099
Cell. 1998 Feb 20;92(4):451-62
pubmed: 9491887
Neurology. 2007 Oct 30;69(18):1789-99
pubmed: 17914061
Neuropathology. 2009 Feb;29(1):13-9
pubmed: 18507770
Cell Host Microbe. 2015 Jan 14;17(1):98-106
pubmed: 25532805
J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):304-9
pubmed: 26859828
Immunol Rev. 2006 Oct;213:180-94
pubmed: 16972904
Retrovirology. 2017 Mar 9;14(1):17
pubmed: 28279181
Antiviral Res. 2015 Mar;115:75-82
pubmed: 25557601
Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089-93
pubmed: 3018755
Am J Pathol. 1995 Nov;147(5):1200-6
pubmed: 7485383
Proc Natl Acad Sci U S A. 1985 Oct;82(20):7086-90
pubmed: 2996004
AIDS Behav. 2014 Sep;18(9):1722-5
pubmed: 25017425
Ann Neurol. 2008 Feb;63(2):213-21
pubmed: 17894380
Virology. 2008 Mar 15;372(2):300-12
pubmed: 18054979
J Biol Chem. 2008 Apr 25;283(17):11772-84
pubmed: 18296443
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1883-8
pubmed: 26858442
Nat Med. 2009 Aug;15(8):893-900
pubmed: 19543283
J Virol. 2015 Oct;89(20):10625-36
pubmed: 26269172
Int J Biochem Cell Biol. 2004 Sep;36(9):1767-75
pubmed: 15183343
Nat Med. 2003 Jun;9(6):727-8
pubmed: 12754504
J Immunol. 2011 Jun 15;186(12):6771-8
pubmed: 21562161
J Virol. 2015 May;89(10):5687-700
pubmed: 25822027
Res Virol. 1990 Mar-Apr;141(2):143-52
pubmed: 1693219
Nat Med. 2017 May;23(5):638-643
pubmed: 28414330
AIDS. 2016 Jan 28;30(3):343-53
pubmed: 26588174
Biomed Pharmacother. 2009 Sep;63(8):561-5
pubmed: 19026516
Genes Dev. 1997 Oct 15;11(20):2633-44
pubmed: 9334326
Nat Med. 2000 Jul;6(7):757-61
pubmed: 10888923
J Virol. 2012 Apr;86(8):4682-7
pubmed: 22318140
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12
pubmed: 24469825
AIDS. 2011 Mar 13;25(5):625-33
pubmed: 21297425
Science. 1986 Sep 5;233(4768):1089-93
pubmed: 3016903
Virus Res. 2005 Aug;111(2):194-213
pubmed: 15885841
PLoS Pathog. 2014 Oct 30;10(10):e1004467
pubmed: 25356757
Nat Rev Microbiol. 2009 Nov;7(11):798-812
pubmed: 19834480
J Virol. 2002 Sep;76(17):8518-31
pubmed: 12163571
J Immunol. 1997 Apr 1;158(7):3499-510
pubmed: 9120312
AIDS Res Hum Retroviruses. 2015 Jan;31(1):64-70
pubmed: 25134819
J Virol. 2000 Dec;74(23):10984-93
pubmed: 11069993
Arch Pathol Lab Med. 1984 Nov;108(11):867-72
pubmed: 6548362
Viruses. 2014 Apr 22;6(4):1837-60
pubmed: 24759213
EMBO J. 2017 Mar 1;36(5):604-616
pubmed: 28122869
Mucosal Immunol. 2014 Sep;7(5):1116-26
pubmed: 24472847
J Clin Invest. 2016 Apr 1;126(4):1353-66
pubmed: 26950420
PLoS Med. 2017 Nov 7;14(11):e1002417
pubmed: 29112956
J Virol. 1998 Dec;72(12):9881-8
pubmed: 9811724
Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6580-4
pubmed: 1631159
Antiviral Res. 2006 Sep;71(2-3):293-300
pubmed: 16806514
J Virol. 2009 Apr;83(8):3518-27
pubmed: 19211771
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):658-63
pubmed: 11136236
J Neurovirol. 2000 May;6 Suppl 1:S53-60
pubmed: 10871766
Retrovirology. 2017 Oct 16;14(1):47
pubmed: 29037245
J Med Virol. 2002 Dec;68(4):479-88
pubmed: 12376954
J Leukoc Biol. 2017 May;101(5):1083-1090
pubmed: 27986871
J Infect Dis. 2015 Nov 1;212(9):1361-5
pubmed: 25877550
Ann Intern Med. 2014 Sep 2;161(5):319-27
pubmed: 25047577
PLoS Pathog. 2013 Feb;9(2):e1003174
pubmed: 23459007
PLoS Pathog. 2011 Oct;7(10):e1002286
pubmed: 22007152
Mol Biol Cell. 2010 Oct 1;21(19):3279-92
pubmed: 20702582
Oncogene. 1998 Dec 17;17(24):3093-102
pubmed: 9872325
PLoS Pathog. 2008 May 02;4(5):e1000057
pubmed: 18451984
Ann Neurol. 1986 Sep;20(3):289-95
pubmed: 3532930
J Exp Med. 2009 Jun 8;206(6):1273-89
pubmed: 19487424
Genes Dev. 1997 Oct 15;11(20):2622-32
pubmed: 9334325
Cell. 1986 Nov 7;47(3):333-48
pubmed: 3094962
AJR Am J Roentgenol. 1986 Nov;147(5):977-83
pubmed: 3490168
AIDS. 2017 Jan 2;31(1):5-14
pubmed: 27898590
Nature. 1986 Oct 23-29;323(6090):725-8
pubmed: 3095663

Auteurs

Viviane Machado Andrade (V)

Molecular Cell and Developmental Biology, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA. vxm147@med.miami.edu.

Mario Stevenson (M)

Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH